PerlJ., HasanO., BargmanJ.M., JiangD., NaY., GillJ.S.Impact of dialysis modality on survival after kidney transplant failure.Clin J Am Soc Nephrol2011; 6: 582–90.
2.
ChionhC.Y., SoniS.S., FinkelsteinF.O., RoncoC., CruzD.N.Use of peritoneal dialysis in AKI: a systematic review.Clin J Am Soc Nephrol2013; 8: 1649–60.
3.
ChoY., JohnsonD.W., BadveS., CraigJ.C., StrippoliG.F., WigginsK.J.Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials.Nephrol Dial Transplant2013; 28: 1899–907.
4.
ChoY., JohnsonD.W., BadveS.V., CraigJ.C., StrippoliG.F., WigginsK.J.The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients.Kidney Int2013; 84: 969–79.
5.
DaviesS.J.What has balANZ taught us about balancing ultrafiltration with membrane preservation?Nephrol Dial Transplant2013; 28: 1971–4.
6.
JohnsonD.W., BrownF.G., ClarkeM., BoudvilleN., EliasT.J., FooM.W.The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial.Perit Dial Int2012; 32: 497–506.
7.
HagenS.M., LafrancaJ.A., IjzermansJ.N., DorF.J.A systematic review and meta-analysis of the influence of peritoneal dialysis catheter type on complication rate and catheter survival.Kidney Int2013; [Epub ahead of print].
